Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii with Special Reference to Carbapenemases: A Systematic Review

References

• Li S, Duan X, Peng Y, Rui Y. Molecular characteristics of carbapenem-resistant Acinetobacter spp. from clinical infection samples and fecal survey samples in Southern China. BMC Infect Dis. 2019;19(1):1–12. doi:10.1186/s12879-019-4423-3
   PubMed Web of Science ®Google Scholar
• Barker J, Maxted H. Observations on the growth and movement of Acinetobacter on semi-solid media. J Med Microbiol. 1975;8(3):443–446. doi:10.1099/00222615-8-3-443
   Web of Science ®Google Scholar
• Gupta N, Gandham N, Jadhav S, Mishra RN. Isolation and identification of Acinetobacter species with special reference to antibiotic resistance. J Nat Sci Biol Med. 2015;6(1):159–162. doi:10.4103/0976-9668.149116
   PubMedGoogle Scholar
• Hamidian M, Nigro SJ. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genom. 2019;5(10). doi:10.1099/mgen.0.000306
   Web of Science ®Google Scholar
• Ramirez MS, Bonomo RA, Tolmasky ME. Carbapenemases: transforming Acinetobacter baumannii into a yet more dangerous menace. Biomolecules. 2020;10(5):720. doi:10.3390/biom10050720
   PubMed Web of Science ®Google Scholar
• Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol. 2018;16(2):91–102. doi:10.1038/nrmicro.2017.148
   PubMed Web of Science ®Google Scholar
• Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(10):3471–3484. doi:10.1128/AAC.01464-06
   PubMed Web of Science ®Google Scholar
• Mezzatesta ML, D’Andrea MM, Migliavacca R, et al. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy. Clin Microbiol Infect. 2012;18(2):160–166. doi:10.1111/j.1469-0691.2011.03527.x
   Web of Science ®Google Scholar
• Zhanel GG, Wiebe R, Dilay L, et al. Comparative review of the carbapenems. Drugs. 2007;67(7):1027–1052. doi:10.2165/00003495-200767070-00006
   PubMed Web of Science ®Google Scholar
• Codjoe FS, Donkor ES. Carbapenem resistance: a review. Med Sci. 2017;6(1):1. doi:10.3390/medsci6010001
   Google Scholar
• Manchanda V, Sanchaita S, Singh NP. Multidrug resistant Acinetobacter. J Glob Infect Dis. 2010;2(3):291–304. doi:10.4103/0974-777X.68538
   PubMedGoogle Scholar
• Said D, Willrich N, Ayobami O, Noll I, Eckmanns T, Markwart R. The epidemiology of carbapenem resistance in Acinetobacter baumannii complex in Germany (2014–2018): an analysis of data from the national Antimicrobial Resistance Surveillance system. Antimicrob Resist Infect Control. 2021;10(1):1–13. doi:10.1186/s13756-021-00909-8
   PubMed Web of Science ®Google Scholar
• Vashist J, Tiwari V, Das R, Kapil A, Rajeswari MR. Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii. Indian J Med Res. 2011;133(3):332.
   Web of Science ®Google Scholar
• Elshamy AA, Aboshanab KM. A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options. Future Sci. 2020;6(3):FSO438. doi:10.2144/fsoa-2019-0098
   Web of Science ®Google Scholar
• Abouelfetouh A, Torky AS, Aboulmagd E. Phenotypic and genotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from Egypt. Antimicrob Resist Infect Control. 2019;8:185. doi:10.1186/s13756-019-0611-6
   PubMed Web of Science ®Google Scholar
• Handal R, Qunibi L, Sahouri I, et al. Characterization of carbapenem-resistant Acinetobacter baumannii strains isolated from hospitalized patients in Palestine. Int J Microbiol. 2017;2017. doi:10.1155/2017/8012104
   Web of Science ®Google Scholar
• Karthikeyan K, Thirunarayan MA, Krishnan P. Coexistence of bla OXA-23 with bla NDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J Antimicrob Chemother. 2010;65(10):2253–2254. doi:10.1093/jac/dkq273
   PubMed Web of Science ®Google Scholar
• Suresh A, Ranjan A, Jadhav S, et al. Molecular genetic and functional analysis of pks-harboring, extra-intestinal pathogenic Escherichia coli from India. Front Microbiol. 2018;9:2631. doi:10.3389/fmicb.2018.02631
   Web of Science ®Google Scholar
• Ranjan A, Shaik S, Nandanwar N, et al. Comparative genomics of Escherichia coli isolated from skin and soft tissue and other extraintestinal infections. mBio. 2017;8:e01070–17. doi:10.1128/mBio.01070-17
   Web of Science ®Google Scholar
• Shaik S, Ranjan A, Tiwari SK, et al. Comparative genomic analysis of globally dominant ST131 clone with other epidemiologically successful extraintestinal pathogenic Escherichia coli (ExPEC) lineages. mBio. 2017;8:e01596–17. doi:10.1128/mBio.01596-17
   Web of Science ®Google Scholar
• Mirza S, Savita jadhav RN, Das NK. Coexistence of β-lactamases in community-acquired infections in a tertiary care hospital in India. Int J Microbiol. 2019;2019:5. doi:10.1155/2019/7019578
   Web of Science ®Google Scholar
• Avasthi TS, Kumar N, Baddam R, et al. Genome of multidrug-resistant uropathogenic Escherichia coli strain NA114 from India. J Bacteriol. 2011;193(16):4272–4273. doi:10.1128/JB.05413-11
   PubMed Web of Science ®Google Scholar
• Jadhav S, Hussain A, Devi S, et al. Virulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi Urban locality in India. PLoS One. 2011;6(3):e18063. doi:10.1371/journal.pone.0018063
   PubMed Web of Science ®Google Scholar
• Nguyen AT, Pham SC, Ly AK, Nguyen CV, Vu TT, Ha TM. Overexpression of bla OXA-58 gene driven by IS Aba3 Is associated with imipenem resistance in a clinical Acinetobacter baumannii isolate from Vietnam. Biomed Res Int. 2020;2020:1–9. doi:10.1155/2020/7213429
   Web of Science ®Google Scholar
• Fernández-Cuenca F, Martínez-Martínez L, Conejo MC, Ayala JA, Perea EJ, Pascual A. Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother. 2003;51(3):565–574. doi:10.1093/jac/dkg097
   PubMed Web of Science ®Google Scholar
• Gehrlein M, Leying H, Cullmann W, Wendt S, Opferkuch W. Imipenem resistance in Acinetobacter baumannii is due to altered penicillin-binding proteins. Chemotherapy. 1991;37(6):405–412. doi:10.1159/000238887
   Web of Science ®Google Scholar
• Uppalapati SR, Sett A, Pathania R. The outer membrane proteins OmpA, CarO, and OprD of Acinetobacter baumannii confer a two-pronged defense in facilitating its success as a potent human pathogen. Front Microbiol. 2020;11:589234. doi:10.3389/fmicb.2020.589234
   PubMed Web of Science ®Google Scholar
• Vrancianu CO, Gheorghe I, Czobor IB, Chifiriuc MC. Antibiotic resistance profiles, molecular mechanisms and innovative treatment strategies of Acinetobacter baumannii. Microorganisms. 2020;8(6):935. doi:10.3390/microorganisms8060935
   PubMed Web of Science ®Google Scholar
• Nguyen M, Joshi SG. Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital‐acquired infections: a scientific review. J Appl Microbiol. 2021;131(6):2715–2738. doi:10.1111/jam.15130
   PubMed Web of Science ®Google Scholar
• Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis. 2006;43(Supplement_2):S49–S56. doi:10.1086/504477
   Web of Science ®Google Scholar
• Vrancianu CO, Pelcaru CF, Alistar A, et al. Escaping from ESKAPE. Clinical significance and antibiotic resistance mechanisms in Acinetobacter baumannii: a review. Biointerface Res Appl Chem. 2021;11(1):8190–8203.
   Web of Science ®Google Scholar
• Ju Y, Kim YJ, Chang CL, Choi GE, Hyun KY. Relationship between AdeABC Efflux pump genes and carbapenem in multidrug-resistant Acinetobacter baumannii. Biomed Sci Lett. 2021;27(2):59–68. doi:10.15616/BSL.2021.27.2.59
   Google Scholar
• Zhang Y, Li Z, He X, et al. Overproduction of efflux pumps caused reduced susceptibility to carbapenem under consecutive imipenem-selected stress in Acinetobacter baumannii. Infect Drug Resist. 2017;11:457–467. doi:10.2147/IDR.S151423
   Web of Science ®Google Scholar
• Xu CF, Bilya SR, Xu W. adeABC efflux gene in Acinetobacter baumannii. New Microbes New Infect. 2019;30:100549. doi:10.1016/j.nmni.2019.100549
   Google Scholar
• Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. Acinetobacter baumannii antibiotic resistance mechanisms. Pathogens. 2021;10(3):373. doi:10.3390/pathogens10030373
   PubMed Web of Science ®Google Scholar
• Ranjan A, Shaik S, Mondal A, et al. Molecular epidemiology and genome dynamics of New Delhi metallo-β-lactamase-producing extraintestinal pathogenic Escherichia coli strains from India. Antimicrob Agents Chemother. 2016;60:6795–6805. doi:10.1128/AAC.01345-16
   Web of Science ®Google Scholar
• Diene SM, Rolain JM. Carbapenemase genes and genetic platforms in Gram-negative bacilli: Enterobacteriaceae, Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2014;20(9):831–838. doi:10.1111/1469-0691.12655
   Web of Science ®Google Scholar
• Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006;12(9):826–836. doi:10.1111/j.1469-0691.2006.01456
   PubMed Web of Science ®Google Scholar
• Pagano M, Martins AF, Barth AL. Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii. Braz J Microbiol. 2016;47:785–792. doi:10.1016/j.bjm.2016.06.005
   PubMed Web of Science ®Google Scholar
• Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother. 2010;54(3):969–976. doi:10.1128/AAC.01009-09
   PubMed Web of Science ®Google Scholar
• Djahmi N, Dunyach-Remy C, Pantel A, Dekhil M, Sotto A, Lavigne JP. Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries. Biomed Res Int. 2014;2014:1–11. doi:10.1155/2014/305784
   Web of Science ®Google Scholar
• Ibrahim ME. Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance. Ann Clin Microbiol Antimicrob. 2019;18(1):1–12. doi:10.1186/s12941-018-0301-x
   PubMed Web of Science ®Google Scholar
• Evans BA, Amyes SG. OXA β-lactamases. Clin Microbiol Rev. 2014;27(2):241–263. doi:10.1128/CMR.00117-13
   PubMed Web of Science ®Google Scholar
• Goudarzi H, Azad M, Seyedjavadi SS, et al. Characterization of integrons and associated gene cassettes in Acinetobacter baumannii strains isolated from intensive care unit in Tehran, Iran. J Acute Dis. 2016;5(5):386–392. doi:10.1016/j.joad.2016.08.004
   Google Scholar
• Suresh A, Shaik S, Baddam R, et al. Evolutionary dynamics based on comparative genomics of pathogenic Escherichia coli lineages harbouring polyketide synthase (pks) island. mBio. 2021;12:e03634–20. doi:10.1128/mBio.03634-20
   Web of Science ®Google Scholar
• Vandecraen J, Chandler M, Aertsen A, Van Houdt R. The impact of insertion sequences on bacterial genome plasticity and adaptability. Crit Rev Microbiol. 2017;43(6):709–730. doi:10.1080/1040841X.2017.1303661
   PubMed Web of Science ®Google Scholar
• Wu W, He Y, Lu J, Lu Y, Wu J, Liu Y. Transition of bla OXA-58-like to bla OXA-23-like in Acinetobacter baumannii clinical isolates in southern China: an 8-year study. PLoS One. 2015;10(9):e0137174. doi:10.1371/journal.pone.0137174
   Web of Science ®Google Scholar
• Segal H, Garny S, Elisha BG. Is IS ABA-1 customized for Acinetobacter? FEMS Microbiol Lett. 2005;243(2):425–429. doi:10.1016/j.femsle.2005.01.005
   Web of Science ®Google Scholar
• Corvec S, Poirel L, Naas T, Drugeon H, Nordmann P. Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene bla OXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(4):1530–1533. doi:10.1128/AAC.01132-06
   Web of Science ®Google Scholar
• Bahador A, Raoofian R, Farshadzadeh Z, et al. The prevalence of ISAba1 and ISAba4 in Acinetobacter baumannii species of different international clone lineages among patients with burning in Tehran, Iran. Jundishapur J Microbiol. 2015;8(7). doi:10.5812/jjm.17167v2
   Web of Science ®Google Scholar
• Ravasi P, Limansky AS, Rodriguez RE, Viale AM, Mussi MA. ISAba825, a functional insertion sequence modulating genomic plasticity and bla OXA-58 expression in Acinetobacter baumannii. Antimicrob Agents Chemother. 2011;55(2):917–920. doi:10.1128/AAC.00491-10
   Web of Science ®Google Scholar
• Lee Y, Kim CK, Lee H, Jeong SH, Yong D, Lee K. A novel insertion sequence, IS Aba10, inserted into IS Aba1 adjacent to the bla OXA-23 gene and disrupting the outer membrane protein gene carO in Acinetobacter baumannii. Antimicrob Agents Chemother. 2011;55(1):361–363. doi:10.1128/AAC.01672-09
   Web of Science ®Google Scholar
• Mussi MA, Limansky AS, Viale AM. Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of β-barrel outer membrane proteins. Antimicrob Agents Chemother. 2005;49(4):1432–1440. doi:10.1128/AAC.49.4.1432-1440.2005
   PubMed Web of Science ®Google Scholar
• Pfeifer Y, Wilharm G, Zander E, et al. Molecular characterization of bla NDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother. 2011;66(9):1998–2001. doi:10.1093/jac/dkr256
   PubMed Web of Science ®Google Scholar
• Bontron S, Nordmann P, Poirel L. Transposition of Tn 125 encoding the NDM-1 carbapenemase in Acinetobacter baumannii. Antimicrob Agents Chemother. 2016;60(12):7245–7251. doi:10.1128/AAC.01755-16
   PubMed Web of Science ®Google Scholar
• Vijayakumar S, Wattal C, Oberoi JK, et al. Insights into the complete genomes of carbapenem-resistant Acinetobacter baumannii harbouring bla OXA-23, bla OXA-420 and bla NDM-1 genes using a hybrid-assembly approach. Access Microbiol. 2020;2:8. doi:10.1099/acmi.0.000140
   Google Scholar
• Vijayakumar S, Anandan S, Prabaa D, et al. Insertion sequences and sequence types profile of clinical isolates of carbapenem-resistant A. baumannii collected across India over four year period. J Infect Public Health. 2020;13(7):1022–1028. doi:10.1016/j.jiph.2019.11.018
   Web of Science ®Google Scholar
• Jones LS, Toleman MA, Weeks JL, Howe RA, Walsh TR, Kumarasamy KK. Plasmid carriage of bla NDM-1 in clinical Acinetobacter baumannii isolates from India. Antimicrob Agents Chemother. 2014;58(7):4211–4213. doi:10.1128/AAC.02500-14
   Web of Science ®Google Scholar
• Chen Y, Gao J, Zhang H, Ying C. Spread of the blaOXA–23-containing Tn 2008 in carbapenem-resistant Acinetobacter baumannii isolates grouped in CC92 from China. Front Microbiol. 2017;8:163. doi:10.3389/fmicb.2017.00163
   Web of Science ®Google Scholar
• Nigro SJ, Hall RM. Structure and context of Acinetobacter transposons carrying the oxa23 carbapenemase gene. J Antimicrob Chemother. 2016;71(5):1135–1147. doi:10.1093/jac/dkv440
   PubMed Web of Science ®Google Scholar
• Yoon EJ, Kim JO, Yang JW, et al. The bla OXA-23-associated transposons in the genome of Acinetobacter spp. represent an epidemiological situation of the species encountering carbapenems. J Antimicrob Chemother. 2017;72(10):2708–2714. doi:10.1093/jac/dkx205
   Web of Science ®Google Scholar
• Mann R, Rafei R, Gunawan C, Harmer CJ, Hamidian M. Variants of Tn 6924, a novel Tn 7 family transposon carrying the bla NDM Metallo-β-Lactamase and 14 Copies of the aphA6 amikacin resistance genes found in Acinetobacter baumannii. Microbiol Spectr. 2022;10(1):e01745–21. doi:10.1128/spectrum.01745-21
   Web of Science ®Google Scholar
• Deylam Salehi M, Ferdosi-Shahandashti E, Yahyapour Y, Khafri S, Pournajaf A, Rajabnia R. Integron-mediated antibiotic resistance in Acinetobacter baumannii isolated from intensive care unit patients, Babol, North of Iran. Biomed Res Int. 2017;2017:1–8. doi:10.1155/2017/7157923
   Web of Science ®Google Scholar
• Nikibakhsh M, Firoozeh F, Badmasti F, Kabir K, Zibaei M. Molecular study of metallo-β-lactamases and integrons in Acinetobacter baumannii isolates from burn patients. BMC Infect Dis. 2021;21(1):1–6. doi:10.1186/s12879-021-06513
   Web of Science ®Google Scholar
• Amin M, Navidifar T, Shooshtari FS, Goodarzi H. Association of the genes encoding metallo-β-lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii. Infect Drug Resist. 2019;12:1171–1180. doi:10.2147/IDR.S196575
   PubMed Web of Science ®Google Scholar
• Yum JH. High prevalence and genotypic characterization of metallo-β-lactamase (MBL)-producing Acinetobacter spp. isolates disseminated in a Korean Hospital. Korean J Clin Lab Sci. 2019;51(4):444–452. doi:10.15324/kjcls.2019.51.4.444
   Google Scholar
• Halaji M, Rezaei A, Zalipoor M, Faghri J. Investigation of class I, II, and III integrons among Acinetobacter Baumannii isolates from hospitalized patients in Isfahan, Iran. Oman Med J. 2018;33(1):37–42. doi:10.5001/omj.2018.07
   PubMedGoogle Scholar
• Kalal BS, Chandran SP, Yoganand R, Nagaraj S. Molecular characterization of carbapenem-resistant Acinetobacter baumannii strains from a tertiary care center in South India. Infectio. 2020;24(1):27–34. doi:10.22354/in.v24i1.824
   Google Scholar
• Aruhomukama D, Najjuka CF, Kajumbula H, et al. blaVIM-and blaOXA-mediated carbapenem resistance among Acinetobacter baumannii and Pseudomonas aeruginosa isolates from the Mulago Hospital intensive care unit in Kampala, Uganda. BMC Infect Dis. 2019;19(1):1–8. doi:10.1186/s12879-019-4510-5
   Web of Science ®Google Scholar
• Sung JY, Koo SH, Cho HH, Kwon KC. AbaR7, a genomic resistance island found in multidrug-resistant Acinetobacter baumannii isolates in Daejeon, Korea. Ann Lab Med. 2012;32(5):324–330. doi:10.3343/alm.2012.32.5.324
   Web of Science ®Google Scholar
• Fournier PE, Vallenet D, Barbe V, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2006;2(1):e7. doi:10.1371/journal.pgen.0020007
   PubMed Web of Science ®Google Scholar
• Nowak P, Paluchowska P. Acinetobacter baumannii: biology and drug resistance—role of carbapenemases. Folia Histochemica Et Cytobiologica. 2016;54(2):61–74. doi:10.5603/FHC.a2016.0009
   Web of Science ®Google Scholar
• Bi D, Xie R, Zheng J, et al. Large-scale identification of AbaR-type genomic islands in Acinetobacter baumannii reveals diverse insertion sites and clonal lineage-specific antimicrobial resistance gene profiles. Antimicrob Agents Chemother. 2019;63(4):e02526–18. doi:10.1128/AAC.02526-18
   Web of Science ®Google Scholar
• Bi D, Zheng J, Xie R, et al. Comparative analysis of AbaR-type genomic islands reveals distinct patterns of genetic features in elements with different backbones. Msphere. 2020;5(3):e00349–20. doi:10.1128/mSphere.00349-20
   Web of Science ®Google Scholar
• Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9(2):148–165. doi:10.1128/CMR.9.2.148
   PubMed Web of Science ®Google Scholar
• Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev. 2007;20(3):440–458. doi:10.1128/CMR.00001-07
   PubMed Web of Science ®Google Scholar
• Paton R, Miles RS, Hood J, Amyes SGB. ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents. 1993;2(2):81–87. doi:10.1016/0924-8579(93
   PubMedGoogle Scholar
• Zarrilli R, Pournaras S, Giannouli M, Tsakris A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents. 2013;41(1):11–19. doi:10.1016/j.ijantimicag.2012.09.008
   PubMed Web of Science ®Google Scholar
• Afzal-Shah M, Woodford N, Livermore DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother. 2001;45(2):583–588. doi:10.1128/AAC.45.2.583-588.2001
   PubMed Web of Science ®Google Scholar
• Brown S, Amyes S. OXA β-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother. 2006;57(1):1–3. doi:10.1093/jac/dki425
   PubMed Web of Science ®Google Scholar
• Yang Z, Wang P, Song P, Li X. Carbapenemase OXA-423: a Novel OXA-23 Variant in Acinetobacter baumannii. Infect Drug Resist. 2020;13:4069–4075. doi:10.2147/IDR.S277364
   Web of Science ®Google Scholar
• Singh M, De Silva PM, Al-Saadi Y, et al. Characterization of extremely drug-resistant and hypervirulent Acinetobacter baumannii AB030. Antibiotics. 2020;9(6):328. doi:10.3390/antibiotics9060328
   Web of Science ®Google Scholar
• Wang Z, Li H, Zhang J, Wang H. Co-Occurrence of bla OXA-23 in the chromosome and plasmid: increased fitness in carbapenem-resistant Acinetobacter baumannii. Antibiotics. 2021;10(10):1196. doi:10.3390/antibiotics10101196
   Web of Science ®Google Scholar
• Brown S, Young HK, Amyes SGB. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect. 2005;11(1):15–23. doi:10.1111/j.1469-0691.2004.01016.x
   PubMed Web of Science ®Google Scholar
• Rodríguez CH, Nastro M, Famiglietti A. Carbapenemases in Acinetobacter baumannii. Review of their dissemination in Latin America. Revista Argentina de Microbiología. 2018;50(3):327–333. doi:10.1016/j.ram.2017.10.006
   Web of Science ®Google Scholar
• Lee YT, Kuo SC, Chiang MC, et al. Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a bla OXA-51-like gene that is intrinsic to A baumannii. Antimicrob Agents Chemother. 2012;56(2):1124–1127. doi:10.1128/AAC.00622-11
   PubMed Web of Science ®Google Scholar
• Leski TA, Bangura U, Jimmy DH, et al. Identification of bla OXA-51-like, bla OXA-58, bla DIM-1, and bla VIM carbapenemase genes in hospital Enterobacteriaceae isolates from Sierra Leone. J Clin Microbiol. 2013;51(7):2435–2438. doi:10.1128/JCM.00832-13
   Web of Science ®Google Scholar
• Bou G, Oliver A, Martínez-Beltrán J. OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother. 2000;44(6):1556–1561. doi:10.1128/AAC.44.6.1556-1561.2000
   PubMed Web of Science ®Google Scholar
• Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother. 2010;54(1):24–38. doi:10.1128/AAC.01512-08
   PubMed Web of Science ®Google Scholar
• Lu PL, Doumith M, Livermore DM, Chen TP, Woodford N. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan Hospital: spread of plasmid-borne OXA-72 carbapenemase. J Antimicrob Chemother. 2009;63(4):641–647. doi:10.1093/jac/dkn553
   Web of Science ®Google Scholar
• Poirel L, Marqué S, Héritier C, Segonds C, Chabanon G, Nordmann P. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2005;49(1):202–208. doi:10.1128/AAC.49.1.202-208.2005
   PubMed Web of Science ®Google Scholar
• Merkier AK, Catalano M, Ramírez MS, et al. Polyclonal spread of blaOXA-23 and blaOXA-58 in Acinetobacter baumannii isolates from Argentina. J Infect Dev Ctries. 2008;2(03):235–240. doi:10.3855/jidc.269
   Google Scholar
• Poirel L, Mansour W, Bouallegue O, Nordmann P. Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97. Antimicrob Agents Chemother. 2008;52(5):1613–1617. doi:10.1128/AAC.00978-07
   Web of Science ®Google Scholar
• Sevillano E, Fernandez E, Bustamante Z, et al. Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing Acinetobacter baumannii isolates in Bolivia. J Med Microbiol. 2012;61(1):80–84. doi:10.1099/jmm.0.032722-0
   Web of Science ®Google Scholar
• Bertini A, Poirel L, Bernabeu S, et al. Multicopy bla OXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(7):2324–2328. doi:10.1128/AAC.01502-06
   Web of Science ®Google Scholar
• Héritier C, Dubouix A, Poirel L, Marty N, Nordmann P. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. J Antimicrob Chemother. 2005;55(1):115–118. doi:10.1093/jac/dkh500
   Web of Science ®Google Scholar
• Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H. OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother. 2009;53(12):5035–5038. doi:10.1128/AAC.00856-09
   PubMed Web of Science ®Google Scholar
• Gionco B, Pelayo JS, Venancio EJ, Cayô R, Gales AC, Carrara-Marroni FE. Detection of OXA-231, a new variant of bla OXA-143, in Acinetobacter baumannii from Brazil: a case report. J Antimicrob Chemother. 2012;67(10):2531–2532. doi:10.1093/jac/dks223
   PubMed Web of Science ®Google Scholar
• Higgins PG, Pérez-Llarena FJ, Zander E, Fernández A, Bou G, Seifert H. OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2013;57(5):2121–2126. doi:10.1128/AAC.02413-12
   PubMed Web of Science ®Google Scholar
• Goncalves D, Cecilio P, Ferreira H. First detection of OXA-48-like producing Acinetobacter baumannii in the faecal flora of nursing home residents in Northern Portugal. In: Twenty-Third European Congress of Clinical Microbiology and Infectious Diseases. Berlin, Germany: European Congress; 2013.
   Google Scholar
• Tognim MC, Gales AC, Penteado AP, Silbert S, Sader HS. Dissemination of IMP-1 metallo-β-lactamase–producing Acinetobacter species in a Brazilian teaching hospital. Infect Control Hosp Epidemiol. 2006;27(7):742–747. doi:10.1086/504356
   PubMed Web of Science ®Google Scholar
• Riccio ML, Franceschini N, Boschi L, et al. Characterization of the metallo-β-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla IMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother. 2000;44(5):1229–1235. doi:10.1128/AAC.44.5.1229-1235
   Web of Science ®Google Scholar
• Chu YW, Afzal-Shah M, Houang ET, et al. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother. 2001;45(3):710–714. doi:10.1128/AAC.45.3.710-714.2001
   PubMed Web of Science ®Google Scholar
• Da Silva GJ, Correia M, Vital C, et al. Molecular characterization of bla IMP-5, a new integron-borne metallo-β-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. FEMS Microbiol Lett. 2002;215(1):33–39. doi:10.1016/S0378-1097(02)00896-0
   Web of Science ®Google Scholar
• Gales AC, Tognim MC, Reis AO, Jones RN. Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital. Diagn Microbiol Infect Dis. 2003;45(1):77–79. doi:10.1016/s0732-8893(02)00500-x
   PubMed Web of Science ®Google Scholar
• Wang H, Guo P, Sun H, et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother. 2007;51(11):4022–4028. doi:10.1128/AAC.01259-06
   Web of Science ®Google Scholar
• Cayô R, Rodrigues-Costa F, Matos AP, Carvalhaes CG, Jové T, Gales AC. Identification of a new integron harboring bla IMP-10 in carbapenem-resistant Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother. 2015;59(6):3687–3689. doi:10.1128/AAC.04991-14
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Nagao M, Matsumura Y, et al. Interspecies dissemination of a novel class 1 integron carrying bla IMP-19 among Acinetobacter species in Japan. J Antimicrob Chemother. 2011;66(11):2480–2483. doi:10.1093/jac/dkr336
   Web of Science ®Google Scholar
• Azizi O, Shakibaie MR, Badmasti F, et al. Class 1 integrons in non-clonal multidrug-resistant Acinetobacter baumannii from Iran, description of the new blaIMP-55 allele in In1243. J Med Microbiol. 2016;65(9):928–936. doi:10.1099/jmm.0.000315
   Web of Science ®Google Scholar
• Yum JH, Yi K, Lee H, et al. Molecular characterization of metallo-b-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla VIM-2 gene cassettes. J Antimicrob Chemother. 2002;49(5):837–840. doi:10.1093/jac/dkf043
   Web of Science ®Google Scholar
• Tsakris A, Ikonomidis A, Pournaras S, et al. VIM-1 metallo-β-lactamase in Acinetobacter baumannii. Emerg Infect Dis. 2006;12(6):981–983. doi:10.3201/eid1206.051097
   PubMed Web of Science ®Google Scholar
• Figueiredo S, Poirel L, Papa A, Koulourida V, Nordmann P. First identification of VIM-4 metallo-β-lactamase in Acinetobacter spp. Clin Microbiol Infect. 2008;14(3):289–290. doi:10.1111/j.1469-0691.2007.01942.x
   Web of Science ®Google Scholar
• Lee MF, Peng CF, Hsu HJ, Chen YH. Molecular characterisation of the metallo-β-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan. Int J Antimicrob Agents. 2008;32(6):475–480. doi:10.1016/j.ijantimicag.2008.07.009
   Web of Science ®Google Scholar
• Lee K, Yum JH, Yong D, et al. Novel acquired metallo-β-lactamase gene, bla SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother. 2005;49(11):4485–4491. doi:10.1128/AAC.49.11.4485-4491.2005
   PubMed Web of Science ®Google Scholar
• Kaase M, Nordmann P, Wichelhaus TA, Gatermann SG, Bonnin RA, Poirel L. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother. 2011;66(6):1260–1262. doi:10.1093/jac/dkr135
   PubMed Web of Science ®Google Scholar
• Kumar M. Identification of a novel NDM variant, blaNDM-3, from a multidrug-resistant Acinetobacter baumannii. Infect Control Hosp Epidemiol. 2016;37(6):747–748. doi:10.1017/ice.2016.66
   Web of Science ®Google Scholar
• Xanthopoulou K, Urrutikoetxea-Gutiérrez M, Vidal-Garcia M, et al. First report of New Delhi Metallo-β-Lactamase-6 (NDM-6) in a clinical Acinetobacter baumannii isolate from Northern Spain. Front Microbiol. 2020;11:589253. doi:10.3389/fmicb.2020.589253
   Web of Science ®Google Scholar
• Shahcheraghi F, Abbasalipour M, Feizabadi MM, Ebrahimipour GH, Akbari N. Isolation and genetic characterization of metallo-β-lactamase and carbapenemase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol. 2011;3(2):68.
   PubMedGoogle Scholar
• Mohamed NM, Raafat D. Phenotypic and genotypic detection of metallo-beta-lactamases in imipenem-resistant Acinetobacter baumannii isolated from a tertiary hospital in Alexandria, Egypt. Res J Microbiol. 2011;6(10):750–760. doi:10.17311/jm.2011.750.760
   Google Scholar
• Girija SA, Jayaseelan VP, Arumugam P. Prevalence of VIM-and GIM-producing Acinetobacter baumannii from patients with severe urinary tract infection. Acta Microbiol Immunol Hung. 2018;65(4):539–550. doi:10.1556/030.65.2018.038
   Web of Science ®Google Scholar
• Robledo IE, Aquino EE, Santé MI, et al. Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother. 2010;54(3):1354–1357. doi:10.1128/AAC.00899-09
   PubMed Web of Science ®Google Scholar
• Moubareck C, Brémont S, Conroy MC, Courvalin P, Lambert T. GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother. 2009;53(8):3579–3581. doi:10.1128/AAC.00072-09
   PubMed Web of Science ®Google Scholar
• Bogaerts P, Naas T, El Garch F, et al. GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium. Antimicrob Agents Chemother. 2010;54(11):4872–4878. doi:10.1128/AAC.00871-10
   Web of Science ®Google Scholar
• Al-Agamy MH, Jeannot K, El-Mahdy TS, et al. First detection of GES-5 carbapenemase-producing Acinetobacter baumannii isolate. Microb Drug Resist. 2017;23(5):556–562. doi:10.1089/mdr.2016.0152
   PubMed Web of Science ®Google Scholar
• Yungyuen T, Chatsuwan T, Plongla R, et al. Nationwide surveillance and molecular characterization of critically drug-resistant Gram-negative bacteria: results of the Research University Network Thailand study. Antimicrob Agents Chemother. 2021;65(9):e00675–21. doi:10.1128/AAC.00675-21
   Web of Science ®Google Scholar
• Ruan Z, Chen Y, Jiang Y, et al. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int J Antimicrob Agents. 2013;42(4):322–328. doi:10.1016/j.ijantimicag.2013.06.019
   PubMed Web of Science ®Google Scholar
• Katip W, Uitrakul S, Oberdorfer P. A comparison of colistin versus colistin plus meropenem for the treatment of carbapenem-resistant Acinetobacter baumannii in critically ill patients: a propensity score-matched analysis. Antibiotics. 2020;9(10):647. doi:10.3390/antibiotics9100647
   Web of Science ®Google Scholar
• Katip W, Uitrakul S, Oberdorfer P. Clinical efficacy and nephrotoxicity of the loading dose colistin for the treatment of carbapenem-resistant Acinetobacter baumannii in critically ill patients. Pharmaceutics. 2021;14(1):31. doi:10.3390/pharmaceutics14010031
   PubMed Web of Science ®Google Scholar
• Katip W, Uitrakul S, Oberdorfer P. Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients. Infect Drug Resist. 2017;10:293. doi:10.2147/IDR.S144314
   PubMed Web of Science ®Google Scholar
• Katip W, Oberdorfer P, Kasatpibal N. Effectiveness and nephrotoxicity of loading dose colistin–meropenem versus loading dose colistin–imipenem in the treatment of carbapenem-resistant Acinetobacter baumannii infection. Pharmaceutics. 2022;14(6):1266. doi:10.3390/pharmaceutics14061266
   PubMed Web of Science ®Google Scholar
• Seok H, Choi WS, Lee S, et al. What is the optimal antibiotic treatment strategy for carbapenem-resistant Acinetobacter baumannii (CRAB)? A multicentre study in Korea. J Glob Antimicrob Resist. 2021;24:429–439. doi:10.1016/j.jgar.2021.01.018
   PubMed Web of Science ®Google Scholar
• Gandham NR, Gupta N, Jadhav SV, Misra RN. Isolation of Acinetobacter baumannii from cerebrospinal fluid following craniotomy. Med J DY Patil Univ. 2012;5:151–153. doi:10.4103/0975-2870.103347
   Google Scholar
• Higgins PG, Schneiders T, Hamprecht A, Seifert H. In vivo selection of a missense mutation in adeR and conversion of the novel bla OXA-164 gene into bla OXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient. Antimicrob Agents Chemother. 2010;54(12):5021–5027. doi:10.1128/AAC.00598-10
   Web of Science ®Google Scholar
• Lin MF, Lan CY. Antimicrobial resistance in Acinetobacter baumannii: from bench to bedside. Journal of Clinical Cases: World J Clin Cases. 2014;2(12):787. doi:10.12998/wjcc.v2.i12.787
   PubMed Web of Science ®Google Scholar
• Cicek AC, Saral A, Iraz M, et al. OXA-and GES-type β-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin Microbiol Infect. 2014;20(5):410–415. doi:10.1111/1469-0691.12338
   PubMed Web of Science ®Google Scholar
• Lee CR, Lee JH, Park M, et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 2017;7:55. doi:10.3389/fcimb.2017.00055
   PubMed Web of Science ®Google Scholar
• Simo Tchuinte PL, Rabenandrasana MA, Kowalewicz C, et al. Phenotypic and molecular characterisations of carbapenem-resistant Acinetobacter baumannii strains isolated in Madagascar. Antimicrob Resist Infect Control. 2019;8(1):1–9. doi:10.1186/s13756-019-0491-9
   Web of Science ®Google Scholar
• El-Badawy MF, Abdelwahab SF, Alghamdi SA, Shohayeb MM. Characterization of phenotypic and genotypic traits of carbapenem-resistant Acinetobacter baumannii clinical isolates recovered from a tertiary care hospital in Taif, Saudi Arabia. Infect Drug Resist. 2019;12:3113. doi:10.2147/IDR.S206691
   Web of Science ®Google Scholar
• El Hafa H, Nayme K, El Hamzaoui N, et al. Dissemination of carbapenem-resistant Acinetobacter baumannii strains carrying the blaGES, blaNDM and blaOXA23 in Morocco. Germs. 2019;9(3):133. doi:10.18683/germs.2019.1168
   Google Scholar
• Huang ZY, Li J, Shui J, Wang HC, Hu YM, Zou MX. Co-existence of bla OXA-23 and bla VIM in carbapenem-resistant Acinetobacter baumannii isolates belonging to global complex 2 in a Chinese teaching hospital. Chin Med J. 2019;132(10):1166–1172. doi:10.1097/CM9.0000000000000193
   Web of Science ®Google Scholar
• Boral B, Unaldi Ö, Ergin A, Durmaz R, Eser ÖK. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features. Ann Clin Microbiol Antimicrob. 2019;18(1):1–9. doi:10.1186/s12941-019-0319-8
   Web of Science ®Google Scholar
• Vijayakumar S, Mathur P, Kapil A, et al. Molecular characterization & epidemiology of carbapenem-resistant Acinetobacter baumannii collected across India. Indian J Med Res. 2019;149(2):240. doi:10.4103/ijmr.IJMR_2085_17
   PubMed Web of Science ®Google Scholar
• Coskun US, Caliskan E, Cicek AC, Turumtay H, Sandalli C. β-lactamase genes in carbapenem resistance Acinetobacter baumannii isolates from a Turkish university hospital. J Infect Dev Ctries. 2019;13(01):50–55. doi:10.3855/jidc.10556
   Web of Science ®Google Scholar
• Guo J, Li C. Molecular epidemiology and decreased susceptibility to disinfectants in carbapenem-resistant Acinetobacter baumannii isolated from intensive care unit patients in central China. J Infect Public Health. 2019;12(6):890–896. doi:10.1016/j.jiph.2019.06.007
   Web of Science ®Google Scholar
• Hoang Quoc C, Nguyen Thi Phuong T, Nguyen Duc H, et al. Carbapenemase genes and multidrug resistance of Acinetobacter baumannii: a cross sectional study of patients with pneumonia in Southern Vietnam. Antibiotics. 2019;8(3):148. doi:10.3390/antibiotics8030148
   Web of Science ®Google Scholar
• Tafreshi N, Babaeekhou L, Ghane M. Antibiotic resistance pattern of Acinetobacter baumannii from burns patients: increase in prevalence of blaOXA-24-like and blaOXA-58-like genes. Iran J Microbiol. 2019;11(6):502–509.
   Web of Science ®Google Scholar
• Tavares LC, Vasconcellos FM, Sousa WV, et al. Emergence and persistence of high-risk clones among MDR and XDR A. baumannii at a Brazilian teaching hospital. Front Microbiol. 2019;9:2898. doi:10.3389/fmicb.2018.02898
   Web of Science ®Google Scholar
• Khaledi M, Shahini Shams Abadi M, Validi M, Zamanzad B, Vafapour R, Gholipour A. Phenotypic and genotypic detection of metallo-β-lactamases in A. baumanii isolates obtained from clinical samples in Shahrekord, southwest Iran. BMC Res Notes. 2019;12(1):1–6. doi:10.1186/s13104-019-4636-y
   Web of Science ®Google Scholar
• Ranjbar R, Farahani A. Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant Acinetobacter baumannii isolated from burn wound infections in Iran. Antimicrob Resist Infect Control. 2019;8(1):1. doi:10.1186/s13756-019-0612-5
   Web of Science ®Google Scholar
• Sharma M, Singhal L, Gautam V, Ray P. Distribution of carbapenemase genes in clinical isolates of Acinetobacter baumannii & a comparison of MALDI-TOF mass spectrometry-based detection of carbapenemase production with other phenotypic methods. Indian J Med Res. 2020;151(6):585. doi:10.4103/ijmr.IJMR_1383_18
   Web of Science ®Google Scholar
• Ezadi F, Jamali A, Heidari A, Javid N, Ardebili A. Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran. J Glob Antimicrob Resist. 2020;21:380–385. doi:10.1016/j.jgar.2019.11.010
   PubMed Web of Science ®Google Scholar
• El-Kazzaz W, Metwally L, Yahia R, Al-Harbi N, El-Taher A, Hetta HF. Antibiogram, prevalence of OXA carbapenemase encoding genes, and RAPD-genotyping of multidrug-resistant Acinetobacter baumannii incriminated in hidden community-acquired infections. Antibiotics. 2020;9(9):603. doi:10.3390/antibiotics9090603
   Web of Science ®Google Scholar
• Rao M, Rashid FA, Shukor S, Hashim R, Ahmad N. Detection of antimicrobial resistance genes associated with carbapenem resistance from the whole-genome sequence of Acinetobacter baumannii isolates from Malaysia. Can J Infect Dis Med Microbiol. 2020. doi:10.1155/2020/5021064
   Web of Science ®Google Scholar
• Azimi L, Fallah F, Karimi A, et al. Survey of various carbapenem-resistant mechanisms of Acinetobacter baumannii and Pseudomonas aeruginosa isolated from clinical samples in Iran. Iran J Basic Med Sci. 2020;23(11):1396–1400. doi:10.22038/IJBMS.2020.44853.10463
   PubMed Web of Science ®Google Scholar
• Thirapanmethee K, Srisiri-A-Nun T, Houngsaitong J, Montakantikul P, Khuntayaporn P, Chomnawang MT. Prevalence of OXA-type β-lactamase genes among carbapenem-resistant Acinetobacter baumannii clinical isolates in Thailand. Antibiotics. 2020;9(12):864. doi:10.3390/antibiotics9120864
   Web of Science ®Google Scholar
• de Freitas SB, Amaral SC, Ferreira MR, et al. Molecular characterization of carbapenem-resistant Acinetobacter baumannii associated with nosocomial infection in the Pelotas, RS, Brazil. Curr Microbiol. 2020;77(10):2724–2734. doi:10.1007/s00284-020-02060-w
   Web of Science ®Google Scholar
• Fam NS, Gamal D, Mohamed SH, et al. Molecular characterization of Carbapenem/Colistin-resistant Acinetobacter baumannii clinical isolates from Egypt by whole-genome sequencing. Infect Drug Resist. 2020;13:4487–4493. doi:10.2147/IDR.S288865
   Web of Science ®Google Scholar
• Nodari CS, Cayô R, Streling AP, et al. Genomic analysis of carbapenem-resistant Acinetobacter baumannii isolates belonging to major endemic clones in South America. Front Microbiol. 2020;11:584603. doi:10.3389/fmicb.2020.584603
   Web of Science ®Google Scholar
• Bansal G, Allen-McFarlane R, Eribo B. Antibiotic susceptibility, clonality, and molecular characterization of carbapenem-resistant clinical isolates of Acinetobacter baumannii from Washington DC. Int J Microbiol. 2020;2120159. doi:10.1155/2020/2120159
   Web of Science ®Google Scholar
• Mortazavi SM, Farshadzadeh Z, Janabadi S, et al. Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran. New Microbes New Infect. 2020;38:100779. doi:10.1016/j.nmni.2020.100779
   Web of Science ®Google Scholar
• Anane YA, Apalata T, Vasaikar S, Okuthe GE, Songca S. Molecular detection of carbapenemase-encoding genes in multidrug-resistant acinetobacter baumannii clinical isolates in South Africa. Int J Microbiol. 2020;1–10. doi:10.1155/2020/7380740
   Web of Science ®Google Scholar
• Lukovic B, Gajic I, Dimkic I, et al. The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates. Antimicrob Resist Infect Control. 2020;9(1):1–2. doi:10.1186/s13756-020-00769-8
   Web of Science ®Google Scholar
• Rezaei A, Fazeli H, Faghri J. Investigation of carbapenem resistant Acinetobacter baumannii ST2 in Iran. Acta Microbiol Immunol Hung. 2021;68(1):20–26. doi:10.1556/030.2020.01164
   Web of Science ®Google Scholar
• Gozalan A, Unaldı O, Guldemir D, et al. Molecular characterization of carbapenem-resistant Acinetobacter baumannii blood culture isolates from three hospitals in Turkey. Jpn J Infect Dis. 2021;74(3):200–208. doi:10.7883/yoken.JJID.2020.478
   Web of Science ®Google Scholar
• Wasfi R, Rasslan F, Hassan SS, Ashour HM, El-Rahman A, Ola A. Co-existence of carbapenemase-encoding genes in Acinetobacter baumannii from cancer patients. Infect Dis Ther. 2021;10(1):291–305. doi:10.1007/s40121-020-00369-4
   Web of Science ®Google Scholar
• Hassan RM, Salem ST, Hassan SI, Hegab AS, Elkholy YS, Chang Y-F. Molecular characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates from Egyptian patients. PLoS One. 2021;16(6):e0251508. doi:10.1371/journal.pone.0251508
   Web of Science ®Google Scholar
• Kostyanev T, Xavier BB, García-Castillo M, et al. Phenotypic and molecular characterizations of carbapenem-resistant Acinetobacter baumannii isolates collected within the EURECA study. Int J Antimicrob Agents. 2021;57(6):106345. doi:10.1016/j.ijantimicag.2021.106345
   Web of Science ®Google Scholar
• Adjei AY, Vasaikar SD, Apalata T, Okuthe EG, Songca SP. Phylogenetic analysis of carbapenem-resistant Acinetobacter baumannii isolated from different sources using Multilocus Sequence Typing Scheme. Infect Genet Evol. 2021;96:105132. doi:10.1016/j.meegid.2021.105132
   Web of Science ®Google Scholar
• Vahhabi A, Hasani A, Rezaee MA, et al. Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync. Iran J Microbiol. 2021;13(3):282. doi:10.18502/ijm.v13i3.6388
   Web of Science ®Google Scholar
• Khuntayaporn P, Kanathum P, Houngsaitong J, Montakantikul P, Thirapanmethee K, Chomnawang MT. Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study. Ann Clin Microbiol Antimicrob. 2021;20(1):1. doi:10.1186/s12941-021-00424-z
   Web of Science ®Google Scholar
• Ejaz H, Ahmad M, Younas S, et al. Molecular epidemiology of extensively-drug resistant Acinetobacter baumannii sequence type 2 co-harboring bla NDM and bla OXA from clinical origin. Infect Drug Resist. 2021;14:1931–9. doi:10.2147/IDR.S310478
   Web of Science ®Google Scholar
• Zhang Y, Ding F, Luo Y, et al. Distribution pattern of carbapenemases and solitary contribution to resistance in clinical strains of Acinetobacter baumannii. Ann Palliat Med. 2021;10:9184–9191. doi:10.21037/apm-21-1805
   Web of Science ®Google Scholar
• Namaei MH, Yousefi M, Askari P, Roshanravan B, Hashemi A, Rezaei Y. High prevalence of multidrug-resistant non-fermentative Gram-negative bacilli harboring blaIMP-1 and blaVIM-1 metallo-beta-lactamase genes in Birjand, south-east Iran. Iran J Microbiol. 2021;13(4):470. doi:10.18502/ijm.v13i4.6971
   Web of Science ®Google Scholar
• Khalil MA, Ahmed FA, Elkhateeb AF, et al. Virulence characteristics of biofilm-forming acinetobacter baumannii in clinical isolates using a Galleria Mellonella Model. Microorganisms. 2021;9(11):2365. doi:10.3390/microorganisms9112365
   Web of Science ®Google Scholar
• Xu X, Xu C, Salisu RB, Xu W. Beta-lactamase gene expression level of hospital-acquired CRAB isolated from children in Picu. Infect Drug Resist. 2021;14:3195. doi:10.2147/IDR.S322604
   Web of Science ®Google Scholar
• Kumari M, Verma S, Venkatesh V, et al. Emergence of blaNDM-1 and blaVIM producing Gram-negative bacilli in ventilator-associated pneumonia at AMR Surveillance Regional Reference Laboratory in India. PLoS One. 2021;16(9):e0256308. doi:10.1371/journal.pone.0256308
   Web of Science ®Google Scholar
• Gandham N, Gupta N, Vyawahare C, Mirza SB, Misra RN. Molecular characterization identifies upstream presence of ISAba1 to OXA carbapenemase genes in carbapenem-resistant Acinetobacter baumannii. J Lab Physicians. 2022;14(01):006–10. doi:10.1055/s-0041-1732809
   Web of Science ®Google Scholar